Vagus Nerve Stimulation (VNS): Bioelectric Neuromodulation

A Scientific Approach to Brain–Body Regulation

When brain function is not where it should be, the problem is often not confined to a single area of the brain or a single symptom.

You may notice or experience:

  • recent stroke or traumatic brain injury requiring structured rehabilitation
  • early or ongoing recovery where optimal brain function needs to be supported
  • incomplete recovery, with persistent cognitive, emotional, or physical difficulties
  • fluctuating symptoms, with good days and bad days
  • persistent “brain fog”, fatigue, or poor concentration
  • anxiety, mood instability, or stress-related dysregulation
  • a sense that something is not right, without a clear explanation

In many of these situations, the underlying issue is not simply the damage or the diagnosis, but how effectively the brain and body are regulating together — often at the heart of persistent symptoms.

Vagus nerve stimulation (VNS) is a form of neuromodulation that targets this regulatory system. Rather than acting through medication, it uses gentle, carefully controlled bioelectrical signals to influence how the brain responds to internal and external signals.

At Ormond Neuroscience, we use non-invasive transcutaneous auricular VNS (taVNS) as part of a broader, structured programme (Neuroharmonics) designed to support regulation, learning, and recovery. This means that stimulation is applied gently through the skin of the ear, without any need for surgery.

Page Contents

What Is Vagus Nerve Stimulation?

Vagus nerve stimulation (VNS) refers to a group of neuromodulation techniques that stimulate the vagus nerve in order to influence brain and body function.

Several forms of VNS exist:

  • implanted VNS, which requires surgery
  • non-invasive cervical VNS, applied to the neck
  • transcutaneous auricular VNS (taVNS), applied to specific regions of the ear

These approaches differ in how they are delivered and in their clinical applications, but they share a common biological principle: influencing communication between the body and the brain through the vagus nerve.

Why the Vagus Nerve Matters

The vagus nerve is one of the primary pathways through which the brain and body communicate.

It carries information from internal organs — including the heart, lungs, and gastrointestinal system — to the brain, helping to regulate:

  • autonomic balance (the interaction between the body’s stress and recovery systems — the sympathetic and parasympathetic nervous systems)
  • arousal and alertness
  • emotional and interoceptive states (the brain’s awareness of signals from within the body, such as heartbeat, breathing, and gut sensations)
  • immune and inflammatory responses

In practice, this means that the vagus nerve plays a central role in how the brain and body maintain physiological and psychological stability, adapt to stress, and regulate internal states.

Given its central regulatory role, the vagus nerve is a biologically plausible and clinically relevant target for neuromodulation.

How is it that Stimulation of the Ear can Influence the Brain?

A small branch of the vagus nerve terminates in specific regions of the ear. Carefully applied stimulation to this region activates brainstem nuclei, which in turn project to systems involved in attention, arousal, learning, regulation, and neuroplasticity — particularly those linked to the brain’s capacity for adaptation.

Rather than forcing the brain to change, VNS modulates the conditions under which change becomes possible — influencing how readily the brain adapts to experience, rehabilitation, and therapy. This distinction is important, as the effectiveness of any intervention depends on the brain’s capacity to regulate itself and integrate new information.

This means that VNS can make the brain more receptive to change — supporting learning, recovery, and adaptation across a range of interventions.

VNS can be used on its own and, depending on the condition being addressed, may produce meaningful benefits. In clinical practice, however, it is most often integrated into a broader treatment approach, such as our Neuroharmonics programme, where it supports regulation, enhances responsiveness to therapy, and contributes to overall recovery.

In some contexts, VNS is paired with specific interventions to enhance their effects. For example, in stroke rehabilitation, combining VNS with upper limb physiotherapy has been shown to produce greater functional gains than physiotherapy alone, with benefits that are sustained over time.

The Neuroharmonics Framework in Practice

Graphic explaining the Neuroharmonics framework and the role of VNS within that treatment protocol.
The diagram illustrates how multiple systems interact to regulate brain function, and where interventions such as VNS can support this process.

Scientific Evidence and Clinical Positioning

Vagus nerve stimulation is not an alternative or fringe intervention. Rather, it is a well-established form of neuromodulation with a substantial and growing evidence base.

Different forms of VNS have been studied extensively and, in some cases, approved for specific medical indications:

  • implanted VNS is approved for drug-resistant epilepsy and treatment-resistant depression
  • non-invasive cervical VNS is approved for certain headache disorders
  • transcutaneous auricular VNS (taVNS) is not yet approved as a standalone medical treatment, but is supported by a growing body of experimental and clinical research

Neuroimaging studies provide direct evidence that VNS influences brain function at a systems level. Functional MRI studies have demonstrated that stimulation of the auricular branch of the vagus nerve activates brainstem nuclei and modulates activity across distributed cortical networks, including regions involved in attention, emotion, and cognitive control. Importantly, these effects are not limited to local activation, but involve changes in network connectivity and efficiency — supporting the view that VNS influences how the brain functions as an integrated system rather than targeting isolated structures.

Core Physiological Effects of VNS

Across studies and clinical contexts, VNS appears to influence a small number of core physiological systems, including:

  • autonomic regulation (including heart-rate variability)
  • neuromodulatory systems involved in learning and neuroplasticity
  • stress and arousal regulation
  • neuroimmune and inflammatory signalling

These shared physiological effects help explain why VNS is beneficial across different conditions without being condition-specific. These effects are not isolated mechanisms, but components of a broader regulatory system that influences how the brain maintains function in the face of physiological stress, injury, or disease.

How VNS Should Be Understood Clinically

Clinical experience and neuroscience research has taught us that the presence of brain pathology does not, on its own, determine clinical outcome. Many individuals are able to maintain cognitive and emotional function despite measurable biological changes associated with neurological or psychiatric conditions. This has led to increasing focus on the regulatory systems that determine how the brain responds to internal and external demands.

Within this context, the vagus nerve can be understood as part of a broader regulatory network that influences whether the brain remains stable, adaptable, and functionally effective under stress or disease burden. Modulating this system does not remove pathology, but may influence how that pathology is expressed at a functional level.

VNS does not remove pathology or directly “fix” a specific condition. Instead, it influences the regulatory systems that determine how the brain functions in the presence of that condition. This distinction is important. Clinical outcomes in brain disorders are determined not only by the underlying pathology, but by the integrity of the systems that regulate brain function. By modulating these systems, VNS may influence how symptoms are expressed and how effectively the brain is able to adapt and recover.

How We Use VNS at Ormond Neuroscience

We use VNS in a structured and deliberate manner, guided by current evidence and sound clinical judgement.

At Ormond Neuroscience, we use taVNS with the following principles:

  • Sub-threshold intensity
    Stimulation is set at a level that is barely perceptible, avoiding discomfort while still engaging the relevant neural pathways. This is the physiological sweet spot for stimulus intensity.
  • Consistency over intensity
    Effects are achieved through repeated, well-timed application rather than high levels of stimulation.
  • Context-dependent use
    VNS may be used on its own or integrated into a broader treatment programme, depending on the clinical context and goals.
  • Integration with rehabilitation and therapy
    Where appropriate, VNS is paired with interventions such as physiotherapy, cognitive rehabilitation, or psychological treatment in order to enhance the effects of these other therapies.

A Structured, Individualised Approach

VNS is not applied in a uniform or generic way. Its use is tailored to the individual, taking into account:

  • the nature of the patient’s condition
  • the stage of recovery (acute, subacute, or chronic)
  • the individual’s symptoms, goals, and response to treatment

In practical terms, this means that VNS is adjusted over time, rather than applied as a fixed protocol.

What Makes This Approach Different

VNS is widely available in consumer and commercial forms, often used without clinical guidance.

At Ormond Neuroscience, it is used as part of a clinician-led framework, where:

  • application is guided by neuropsychological assessment and the patient’s diagnosis and medical history
  • use is integrated with broader rehabilitation strategies
  • progress is monitored and adjusted over time

This structured approach is intended to maximise benefit while maintaining safety and clinical relevance.

What VNS Can — and Cannot — Do

Vagus nerve stimulation is a powerful tool, but it is not a cure and should not be understood in those terms. Its effects should be understood in relation to regulation, adaptation, and responsiveness to intervention.

What VNS Can Do

VNS can:

  • support physiological and emotional regulation
  • enhance the brain’s capacity for learning and neuroplasticity
  • improve responsiveness to rehabilitation, therapy, and behavioural change
  • modulate systems involved in stress, arousal, and adaptation
  • influence inflammatory processes

These effects may contribute to meaningful improvements in function over time, particularly when VNS is used consistently and appropriately.

What VNS Cannot Do

VNS cannot:

  • remove structural damage or underlying pathology
  • replace comprehensive rehabilitation, psychotherapy, or medical care
  • act as a passive or instantaneous solution
  • guarantee outcomes independent of context, effort, and engagement

Clear expectations are essential.

VNS works by influencing the conditions under which change becomes possible. Its effectiveness therefore depends on how it is used, the context in which it is applied, and the broader treatment approach.

Relationship to Medication

Vagus nerve stimulation is not positioned as a replacement for medical treatment. Medication remains an essential component of care in many neurological and psychiatric conditions, and appropriate prescribing can be critically important.

At the same time, it is increasingly recognised that outcomes are not determined by medication alone. In some cases, individuals may be prescribed multiple psychotropic medications with only partial benefit, reflecting the complexity of brain-based conditions and the limitations of a purely pharmacological approach.

Within this context, VNS is used as part of a broader, integrative framework. Its role is to support regulation and improve the brain’s responsiveness to intervention, which may, in some cases, allow for simplification of treatment over time under appropriate medical supervision.

Learn More

For further information about vagus nerve stimulation and its clinical applications, please see the following pages:

Ormond Neuroscience Web Pages

Talks and Interviews

For those interested in a deeper exploration of the neuroscience and clinical application of VNS, the following talks and interviews provide additional context:

Get in Touch

If you would like to explore whether vagus nerve stimulation is appropriate for your situation, please get in touch to arrange an initial consultation. Further details are available on our Contact page.

Frequently Asked Questions

Is vagus nerve stimulation safe?
Non-invasive vagus nerve stimulation is generally well tolerated when used appropriately. At Ormond Neuroscience, stimulation is applied at low, sub-threshold levels and adjusted based on individual response.

Does vagus nerve stimulation hurt?
Stimulation is typically barely perceptible. Most individuals experience either no sensation or a mild tingling at the site of application.

Do I need surgery for VNS?
No. The approach used at Ormond Neuroscience is non-invasive, with stimulation applied through the skin of the ear.

Can VNS be used on its own?
VNS can be used on its own and may produce meaningful effects in some individuals. In many cases, however, it is integrated into a broader treatment approach to support overall outcomes.

What conditions can VNS help with?
VNS is used in a range of neurological and psychiatric contexts, including stroke rehabilitation, epilepsy, mood disorders, and conditions involving dysregulation of brain–body systems.

Will VNS replace my medication?
VNS is not positioned as a replacement for medication. In some cases, medication may be reduced over time and with appropriate medical supervision, but medication decisions are always made on an individual basis.

Selected References and Evidence Base

Badran, B. W., Brown, J. C., Dowdle, L. T., Mithoefer, O. J., & George, M. S. (2018). Tragus or cymba conchae? Investigating the anatomical foundation of transcutaneous auricular vagus nerve stimulation (taVNS). Brain Stimulation, 11(4), 947–948. https://doi.org/10.1016/j.brs.2018.06.003

Ben-Menachem, E., Revesz, D., Simon, B. J., & Silberstein, S. (2015). Surgically implanted and non-invasive vagus nerve stimulation: A review of efficacy, safety and tolerability. European Journal of Neurology, 22(9), 1260–1268. https://doi.org/10.1111/ene.12629

Engineer, N. D., Kimberley, T. J., Prudente, C. N., Dawson, J., Tarver, W. B., Hays, S. A., & Kilgard, M. P. (2019). Targeted vagus nerve stimulation for rehabilitation after stroke. Frontiers in Neuroscience, 13, 280. https://doi.org/10.3389/fnins.2019.00280

Frangos, E., Ellrich, J., & Komisaruk, B. R. (2015). Non-invasive access to the vagus nerve via the external ear: fMRI evidence for activation of vagal afferents. Brain Stimulation, 8(3), 624–636. https://doi.org/10.1016/j.brs.2014.11.018

George, M. S., Ward, H. E., Ninan, P. T., Pollack, M., Nahas, Z., Anderson, B., … Ballenger, J. C. (2008). A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimulation, 1(2), 112–121. https://doi.org/10.1016/j.brs.2008.02.001

Hays, S. A., Rennaker, R. L., & Kilgard, M. P. (2013). Targeting plasticity with vagus nerve stimulation to treat neurological disease. Progress in Brain Research, 207, 275–299. https://doi.org/10.1016/B978-0-444-63327-9.00010-2

He, W., Jing, X., Zhu, B., Zhu, X., Li, L., & Ben, H. (2013). The auriculo-vagal afferent pathway and its role in seizure suppression in rats. BMC Neuroscience, 14, 85. https://doi.org/10.1186/1471-2202-14-85

Krahl, S. E., Clark, K. B., Smith, D. C., & Browning, R. A. (1998). Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia, 39(7), 709–714. https://doi.org/10.1111/j.1528-1157.1998.tb01152.x

Liu, J., Fang, J., Wang, Z., Rong, P., Hong, Y., Fan, Y., … Kong, J. (2016). Transcutaneous vagus nerve stimulation modulates amygdala functional connectivity in patients with depression. Journal of Affective Disorders, 205, 319–326. https://doi.org/10.1016/j.jad.2016.08.003

Rong, P., Liu, A., Zhang, J., Wang, Y., He, W., Yang, A., … Ben, H. (2016). Transcutaneous vagus nerve stimulation for refractory epilepsy: A randomized controlled trial. Clinical Science, 130(20), 1785–1794. https://doi.org/10.1042/CS20130518

Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61(3), 201–216. https://doi.org/10.1016/S0165-0327(00)00338-4

Vonck, K., Raedt, R., Naulaerts, J., De Vogelaere, F., Thiery, E., & Van Roost, D. (2014). Vagus nerve stimulation… 25 years later! What do we know about the effects on cognition? Neuroscience & Biobehavioral Reviews, 45, 63–71. https://doi.org/10.1016/j.neubiorev.2014.05.005

Yakunina, N., Kim, S. S., & Sven Bestmann. (2017). Optimization of transcutaneous vagus nerve stimulation using functional MRI. Neurolmage: Clinical, 19, 170–181. https://doi.org/10.1111/ner.12541

Yuan, H., & Silberstein, S. D. (2016). Vagus nerve and vagus nerve stimulation, a comprehensive review: Part I. Headache, 56(1), 71–78. https://doi.org/10.1111/head.12647

An ornamental flourish